• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Exhibit 3-2. Requirements for Physicians' Waivers To Dispense or Prescribe Buprenorphine and Buprenorphine-Naloxone to Patients Who Are Opioid Addicted

“To qualify for a waiver under DATA 2000 a licensed physician (MD or DO) must meet any one or more of the following criteria:
• The physician holds a subspecialty board certification in addiction psychiatry from the American Board of Medical Specialties.
• The physician holds an addiction certification from the American Society of Addiction Medicine.
• The physician holds a subspecialty board certification in addiction medicine from the American Osteopathic Association.
• The physician has, with respect to the treatment and management of opioid-addicted patients, completed not less than eight hours of training (through classroom situations, seminars at professional society meetings, electronic communications, or otherwise) that is provided by the American Society of Addiction Medicine, the American Academy of Addiction Psychiatry, the American Medical Association, the American Osteopathic Association, the American Psychiatric Association, or any other organization that the Secretary [of Health and Human Services] determines is appropriate for purposes of this subclause.
• The physician has participated as an investigator in one or more clinical trials leading to the approval of a narcotic drug in schedule III, IV, or V for maintenance or detoxification treatment, as demonstrated by a statement submitted to the Secretary by the sponsor of such approved drug.
• The physician has such other training or experience as the State medical licensing board (of the State in which the physician will provide maintenance or detoxification treatment) considers to demonstrate the ability of the physician to treat and manage opioid-addicted patients.
• The physician has such other training or experience as the Secretary considers to demonstrate the ability of the physician to treat and manage opioid-addicted patients. Any criteria of the Secretary under this subclause shall be established by regulation. Any such criteria are effective only for 3 years after the date on which the criteria are promulgated, but may be extended for such additional discrete 3-year periods as the Secretary considers appropriate for purposes of this subclause. Such an extension of criteria may only be effectuated through a statement published in the Federal Register by the Secretary during the 30-day period preceding the end of the 3-year period involved.”

From: Chapter 3. Pharmacology of Medications Used To Treat Opioid Addiction

Cover of Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs
Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs.
Treatment Improvement Protocol (TIP) Series, No. 43.
Center for Substance Abuse Treatment.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.